Immunogenicity, tolerance and reactogenicity of Quimi-Hib and alum phospate adjuvanted Quimi-Hib vaccines in healthy infants according to 6 - 10 - 14 weeks primary vaccination series. A multicenter, controlled, randomized, doubled blind clinical trial
Latest Information Update: 14 Oct 2020
Price :
$35 *
At a glance
- Drugs Hib vaccine conjugate (Primary) ; Aluminium phosphate
- Indications Haemophilus infections
- Focus Therapeutic Use
- 01 Jun 2020 Status changed from planning to not yet recruiting.
- 28 Sep 2012 New trial record